LifeVantage Q2 Revenue 2023 Down 3.8% To $51.6 Million
LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its second fiscal quarter ended December 31, 2023. Second Quarter Fiscal 2024...
LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its second fiscal quarter ended December 31, 2023. Second Quarter Fiscal 2024...
What's Your Reaction?
